Brind.

Entities / Person

Alex Zhavoronkov.

scientist

Seen in 7 reportsLast reported Sep 9

Reports this week: 0
Active events: 0
Connections: 2

What's happening

Reports per dayLast 90 days

90 days agoDrag either end to show only events that began in that periodToday

One to three months ago

Insilico's AI platform developed rentosertib for IPF, and CEO Alex Zhavoronkov presented findings at Sorbonne.

Some support1 report

Around Alex Zhavoronkov this week

News at the entities that move Alex Zhavoronkov most

Insilico Medicine Structural
Insilico Medicine developed PLSI for the Grok Bot platform in collaboration with David Sinclair, a researcher from Harvard Medical School.

Moves Alex Zhavoronkov
Fri 16:58

Connections

Strongest first. The bars show how strongly a change on one side reaches the other.

Insilico Medicine Structural

Alex Zhavoronkov serves as the Founder and Co-CEO of Insilico Medicine.

Well supportedSep 9

Alex Zhavoronkov → Insilico Medicine
Insilico Medicine → Alex Zhavoronkov
Sorbonne University Shared context

Alex Zhavoronkov presented findings at Sorbonne University.

Some supportSep 8

Alex Zhavoronkov → Sorbonne University
Sorbonne University → Alex Zhavoronkov

History

Events by the month they began

September 2026

1 event

Sep 8, 2026Insilico's AI platform developed rentosertib for IPF, and CEO Alex Zhavoronkov presented findings at Sorbonne.